Loading
IP
Innovus Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by ARMISTICE CAPITAL, LLC, was filed 18 Sept 2019.
Innovus Pharmaceuticals, Inc.: what insiders have been doing
Innovus Pharmaceuticals, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Innovus Pharmaceuticals, Inc. has had no insider filing for more than a year; the last one goes back to 19 February 2020.
Over the whole record (from 2016), the tally stands at 10 purchases and no sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
15
Thresholds
n/a
Buy Volume
€51,070
10 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2018FY ended December 2018 · cache
Income statement
Revenue21.4M
Gross profit4.3k0% margin
Net income-7.4M-34.5% margin
Last declaration on 19 February 2020
Declarations15 total
300,000 sharesCommon StockSEC:0000919574-20-001731:0
00Common StockSEC:0000919574-20-001731:1
300,000 sharesCommon StockSEC:0000919574-20-001732:0
00Common StockSEC:0000919574-20-001732:1
00Common StockSEC:0000919574-19-005932:1
Canonical exit: 15 Dec 2019 (T+90)
00Common StockSEC:0000919574-19-005932:3
Canonical exit: 16 Dec 2019 (T+90)
9,183 shares@ US$2.4849.0% of flowCommon StockSEC:0000919574-19-005932:0
Canonical exit: 15 Dec 2019 (T+90)
9,000 shares@ US$2.6551.0% of flowCommon StockSEC:0000919574-19-005932:2
Canonical exit: 16 Dec 2019 (T+90)
90,000 shares@ US$0.092689.7% of flowCommon StockSEC:0001415889-17-001861:0
Canonical exit: 21 Feb 2018 (T+90)
5,000 shares@ US$0.0945.1% of flowCommon StockSEC:0001415889-17-001861:1
Canonical exit: 21 Feb 2018 (T+90)
5,000 shares@ US$0.09765.3% of flowCommon StockSEC:0001415889-17-001861:2
Canonical exit: 21 Feb 2018 (T+90)
4,990 shares@ US$0.096842.1% of flowCommon StockSEC:0001415889-17-001860:0
Canonical exit: 20 Feb 2018 (T+90)
4,900 shares@ US$0.096741.3% of flowCommon StockSEC:0001415889-17-001860:1
Canonical exit: 20 Feb 2018 (T+90)
2,000 shares@ US$0.095416.6% of flowCommon StockSEC:0001415889-17-001860:3
Canonical exit: 20 Feb 2018 (T+90)
12,808,796 shares0Common StockSEC:0001144204-16-137762:0
15 of 15 declarations
About Innovus Pharmaceuticals, Inc.
Innovus Pharmaceuticals, Inc. is a company focused on the development and commercialization of innovative pharmaceutical products. It aims to address unmet medical needs.
